Current Clinical Trials

MDRI Current Studies

Qualified study participants will receive study drug, related testing, and compensation for their time and travel.

Psoriasis Clinical Trials

Eczema Clinical Trials

Boehringer-Ingelheim Merck 8226-003
Pfizer 1082 Regeneron
Galderma – Pediatric

Symbio M518101

Symbio M518101


Translational Research Protocols in Collaboration with the Baylor Institute for Immunology Research (BIIR)

• Evaluation of cardiovascular risk using coronary artery calcium scores in psoriasis patients;

Baylor IRB #: 013-156

• Immune signatures of psoriasis and other skin disorders; Baylor IRB #: 007-024